Evidence map›Paper›PMID 40232798›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

CD70 recruitment to the immunological synapse is dependent on CD20 in B cells.

Abbey B Arp, Andrea Abel Gutierrez, Martin Ter Beest, Guus A Franken, Harry Warner, Andrea Rodgers Furones, Angelique N Kenyon, Franziska Jäger, Alfredo Cabrera-Orefice, Kathrin Kläsener and 14 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Abbey B Arp *Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0009-0003-6727-3273
Andrea Abel Gutierrez *Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0009-0006-9098-7268
Martin Ter BeestDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.
Guus A FrankenDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0009-0008-0905-6373
Harry WarnerDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.
Andrea Rodgers FuronesDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0000-0002-0635-4470
Angelique N KenyonDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0009-0005-9295-1923
Franziska JägerDepartment of Chemistry, Structural Biochemistry, Bijvoet Centre for Biomolecular Research, Faculty of Science, Utrecht University Utrecht 3584 CH, The Netherlands.
Alfredo Cabrera-OreficeRadboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0000-0002-2042-3794
Kathrin KläsenerDepartment of Molecular Immunology, Centre for Biological Signalling Studies and Centre for Integrative Biological Signalling Studies, Centre for Biological Signalling Studies, Biology III, Faculty of Biology, University of Freiburg, Freiburg 79104, Germany.ORCID 0000-0002-5969-2553
Sjoerd van DeventerDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0000-0001-8972-6665
Lenny DroesenDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.
Vera Marie E DunlockDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.
René ClassensDepartment of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.
Julian StaniekDepartment of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.
Jannie BorstDepartment of Immunology, Leiden University Medical Center, Leiden 2333 ZG, The Netherlands.ORCID 0000-0002-8043-5009
Michael RethDepartment of Molecular Immunology, Centre for Biological Signalling Studies and Centre for Integrative Biological Signalling Studies, Centre for Biological Signalling Studies, Biology III, Faculty of Biology, University of Freiburg, Freiburg 79104, Germany.ORCID 0000-0002-1025-7198
Ulrich BrandtRadboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0000-0003-1869-6811
Piet GrosDepartment of Chemistry, Structural Biochemistry, Bijvoet Centre for Biomolecular Research, Faculty of Science, Utrecht University Utrecht 3584 CH, The Netherlands.ORCID 0000-0002-7782-2585
Taco W KuijpersDepartment of Pediatric Immunology, Rheumatology and Infectious Diseases, Emma Children's Hospital, Amsterdam University Medical Center, Amsterdam 1105 AZ, The Netherlands.ORCID 0000-0002-7421-3370
Mirjam H M HeemskerkDepartment of Hematology, Leiden University Medical Center, Leiden 2333 ZG, The Netherlands.ORCID 0000-0001-6320-9133
Marta RizziDepartment of Rheumatology and Clinical Immunology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg 79106, Germany.
Laia Querol Cano *Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0000-0002-7650-9407
Annemiek B van Spriel *Department of Medical BioSciences, Radboud Institute for Medical Innovation, Radboud University Medical Center, Nijmegen 6525 GA, The Netherlands.ORCID 0000-0002-3590-2368

Funding

Deutsche Forschungsgemeinschaft (DFG) 471011418 project A01 and SFB1160 - 256073931 project B02EC | European Research Council (ERC) projects 724281 and 101112687KWF Kankerbestrijding (DCS) projects 12949 and 14726Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) ICI00023ZonMw (Netherlands Organisation for Health Research and Development) project 09120012010023
6 · The paper itself

Abstract

CD20 is a four-transmembrane protein expressed at the surface of B cells from late pro-B cells to memory B cells, with the exception of plasma cells. Its expression pattern makes it an attractive therapeutic target for different B cell malignancies and autoimmune diseases. Despite the clinical success of CD20-targeting antibodies, the biology of the CD20 protein is still not well understood. We investigated CD20 binding partners in the membrane of human B cells using immunoprecipitation followed by mass spectrometry analysis. We identified a molecular interaction between CD70 and CD20, and confirmed this using proximity ligation assays. CD20-CD70 spatiotemporal colocalization was validated at the plasma membrane of B cells using high-resolution microscopy. Cell surface expression of CD70 was found to be enhanced upon CD20 overexpression, suggesting a role for CD20 in stabilizing CD70 at the B cell membrane. Moreover, we observed impaired B-T cell synapse formation and defective recruitment of CD70 to the immunological synapse in the absence of CD20. Impaired synapse formation was confirmed by deleting CD20 in primary B cells, and analysis of B cells from a CD20-deficient patient. Finally, CD20-deletion resulted in diminished T cell activation and cytokine secretion. Together, this study demonstrates that CD20 interacts with CD70 at the B cell membrane, and that CD20 is required for immune synapse formation between B and T cells and consequent T cell activation.

Indexed as

Antigens, CD20B-LymphocytesCD27 LigandImmunological SynapsesCell MembraneHumansLymphocyte ActivationT-LymphocytesAntigens, CD20CD27 LigandCD70 protein, humanB lymphocytesCD20CD70immune synapse

Identifiers

PMID40232798
PMCPMC12037035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.